乙肝疫苗联合乙型肝炎免疫球蛋白接种阻断血清HBsAg阳性母亲HBV母婴传播效果分析*

doi:10.3969/j.issn.1672-5069.2018.06.007

摘要/Abstract

摘要： 目的分析乙肝疫苗联合乙型肝炎免疫球蛋白（HBIG）接种阻断血清HBsAg阳性母亲乙型肝炎病毒（HBV）母婴垂直传播的效果。方法在血清HBsAg阳性母亲所分娩的712例新生儿中,356例接受标准乙肝疫苗,另356例在接种乙肝疫苗的同时,接受 HBIG接种,比较1~10岁儿童接种成功率和HBV母婴垂直传播阻断率。结果在56例1~2岁、234例3~4岁、249例5~6岁、135例7~8岁和38例9~10岁年龄组儿童,血清抗-HBs阳性率分别为89.3%、87.6%、81.1%、83.7%和76.3%,HBsAg阳性率分别为0.0%、0.4%、0.4%、1.5%和2.6%,各年龄组比较,无显著性统计学差异（P>0.05）;联合接种与乙肝疫苗接种组血清抗-HBs阳性率分别为84.3%和64.3%,血清HBsAg阳性率分别3.1%和15.2%,两组差异显著（P<0.05）;在血清HBsAg/HBeAg双阳性母亲所分娩的儿童,246例联合接种组血清HBsAg阳性率为1.6%,显著低于162例只接种乙肝疫苗组的11.7%（P<0.05）,而在血清HBsAg阳性母亲所分娩的儿童,110例联合接种与194例只接种乙肝疫苗组比,血清HBsAg阳性率无显著性差异（2.7%对6.2%,P>0.05）。结论对血清HBsAg/HBeAg双阳性母亲所分娩的新生儿,给予乙肝疫苗联合HBIG接种可能更有效地阻断HBV母婴垂直传播。

关键词: 乙肝疫苗, 乙型肝炎免疫球蛋白, 母婴传播, 阻断

Abstract: Objective To investigate the efficacy of combination inoculation of hepatitis B vaccine and hepatitis B immunoglobulin（HBIG） on blocking mother-to-child transmission of hepatitis B virus infection in newborn with serum HBsAg/HBeAg-positive mothers. Methods 712 newborns with serum HBsAg（n=304） or HBsAg/HBeAg-positive （n=408） mothers were inoculated with hepatitis B vaccine （n=356） or hepatitis B vaccine and HBIG combination（n=356）. The children were followed-up for ten years. Results Serum anti-HBs positive rates were 89.3%,87.6%,81.1%,83.7% and 76.3% in 56 children at age of 1-2 yr,234 at of 3-4 yr,249 at of 5-6 yr,135 at of 7-8 yr and 38 at of 9-10 yr,and serum HBsAg positive rates were 0.0%,0.4%,0.4%,1.5% and 2.6%,respectively,without significant differences among the five groups（P>0.05）;serum anti-HBs positive rate in combination inoculation group was 84.3%,much higher,while serum HBsAg positive rate was 3.1%,much lower than in hepatitis B vaccine inoculation group（64.3% and 15.2%,respectively,P<0.05）;in children with serum double HBsAg/HBeAg positive mothers,serum HBsAg positive rate in 246 children with combination inoculation was 1.6%,much lower than 11.7% （P<0.05） in 162 children with hepatitis B vaccine inoculation alone,while in children with serum HBsAg positive mothers,there was no significant difference as respect to their serum HBsAg positive rates（2.7% vs. 6.2%,P>0.05） in 110 children with combination and 194 with hepatitis B vaccine inoculation. Conclusions The hepatitis B vaccine combined with HBIG inoculation in newborns with serum double HBsAg/HBeAg positive mothers might block HBV mother to child transmission,which is worthy of clinical observation.

Key words: Hepatitis B vaccine, Hepatitis B immunoglobulin, Mother-to-child transmission, Blocking

徐国荣, 柴丽莉. 乙肝疫苗联合乙型肝炎免疫球蛋白接种阻断血清HBsAg阳性母亲HBV母婴传播效果分析^*[J]. 实用肝脏病杂志, 2018, 21(6): 851-854.

Xu Guorong, Chai Lili.. Efficacy of combination inoculation of hepatitis B vaccine and hepatitis B immunoglobulin on blocking mother-to-child transmission of hepatitis B virus infection in newborn with serum HBsAg/HBeAg-positive mothers[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 851-854.

参考文献

[1] Rubenstein JH,Enns R,Heidelbaugh J,et al.American Gastroenterological Association Institute Guideline on the diagnosis and management of Lynch syndrome. Gastroenterology,2015,149(3):16-17.
[2] Parker BD,Schurgers LJ,Brandenburg VM,et al.The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease:the Heart and Soul Study. World J Gastroenterol,2014,20(40):14615-14619.
[3] Biondo MI,Germano V,Pietrosanti M,et al.Lack of hepatitis B virus reactivation after anti-tumour necrosis factor treatment in potential occult carriers with chronic inflammatory arthropathies. Eur J Intern Med,2014,25(5):482-484.
[4] Monjezi R,Tan SW,Tey BT,et al.Detection of hepatitis B virus core antigen by phage display mediated TaqMan real-time immuno-PCR. J Virol Methods,2013,187(1):121-126.
[5] 和沁园,韩国荣,岳欣,等.乙型肝炎e抗原阴性的慢性乙型肝炎病毒感染孕妇孕期和产后肝功能异常及新生儿感染情况分析.中华实用诊断与治疗杂志,2017,31(12):1230-1232.
[6] Jaramillo CM,De FLH,Porras A,et al.Characterization of hepatitis B virus in Amerindian children and mothers from Amazonas State,Colombia. Plos One,2017,12(10):1816-1823.
[7] Apiung T,Ndanu TA,Mingle JA,et al.Hepatitis B virus surface antigen and antibody markers in children at a major paediatric hospital after the pentavalent DTP-HBV-Hib vaccination. J Intensive Care Med,2017,51(1):13-18.
[8] Pfefferkorn M,Bohm S,Schott T,et al.Quantification of large and middle proteins of hepatitis B virus surface antigen (HBsAg) as a novel tool for the identification of inactive HBV carriers. Gut,2017,31(16):31-38.
[9] Blanch L,Sales B,Montanya J,et al.Validation of the Better Care,system to detect ineffective efforts during expiration in mechanically ventilated patients:a pilot study. J Intensive Care Med,2012,38(5):772-780.
[10] Alidjinou EK,Michel C,Canva V,et al.Very slow decline of hepatitis B virus surface antigen and core related antigen in chronic hepatitis B patients successfully treated with nucleos(t)ide analogues. J Med Virol,2018,13(21):2469-2475.
[11] Han W,Ni Q,Liu K,et al.Decreased CD122 on CD56 dim,NK associated with its impairment in asymptomatic chronic HBV carriers with high levels of HBV DNA,HBsAg and HBeAg. Life Sci,2018,22(8):53-60.
[12] 马勇. 乙型肝炎病毒携带孕妇乳汁和血清HBV DNA载量与婴儿感染率的关系分析. 实用肝脏病杂志,2017,20(4):486-487.
[13] Fuchino M,Tajiri K,Minemura M,et al.Vanishing tumor in a liver graft from a hepatitis B virus surface antigen-positive donor. J Intensive Care Med,2017,11(3):610-615.
[14] Simonetti G,Gitto S,Golfieri L,et al.Quality of life of hepatitis B virus surface antigen-positive patients with suppressed viral replication:comparison between inactive carriers and nucleot(s)ide analog-treated patients. Eur J Gastroen Hepat,2018,16(3):1983-1987.
[15] 侯春艳,杨永峰. 慢性乙型肝炎抗病毒治疗新进展. 实用肝脏病杂志,2017,20(1):124-128.
[16] Huang R,Wang J,Hao Y,et al.Letter:the potential risk of HBV reactivation in patients with resolved HBV infection during direct-acting antiviral therapy. Aliment Pharmacol Ther, 2017,46(7):702-707.
[17] Morsica G,Bagaglio S,Spagnuolo V,et al.Immune response to hepatitis B vaccination in HIV-positive individuals with isolated antibodies against hepatitis B core antigen:Results of a prospective Italian study. Plos One,2015,62(9):536-537.
[18] Bui TTT,Tan TT,Nghiem MN,et al.Molecular characterization of hepatitis B virus in Vietnam. Bmc Infect Dis,2017,17(1):601-609.
[19] Benyakov G,Devika K,Etzion O,et al.A misleading pattern of serologic findings during hepatitis B virus infection. Ann Intern Med,2017,167(8):476-482.
[20] Chernet A,Yesuf A,Alagaw A.Seroprevalence of hepatitis B virus surface antigen and factors associated among pregnant women in Dawuro zone,SNNPR,Southwest Ethiopia:a cross sectional study. Bmc Res Notes,2017,10(1):418-423.
[21] Wang H,Cai BY,Rao DL,et al.Rapid immunization effects of a new type of 60 μg hepatitis B vaccine compared with traditional 20 μg hepatitis B vaccines in adults. Hum Vaccin Immunother,2016,12(11):2921-2926.
[22] Shouval D,Roggendorf H,Roggendorf M.Enhanced immune response to hepatitis B vaccination through immunization with a re-S1/Pre-S2/S Vaccine. Med Microbiol Immunol,2015,204:57-68.
[23] Leroux-Roels G,Haelterman E,Maes C,et al.Randomized trial of the immunogenicity and safety of the hepatitis B vaccine given in an accelerated schedule coadministered with the human papillomavirus type 16/18 AS04-adjuvanted cervical cancer vaccine. Clin Vaccine Immunol,2011,18(9):1510-1518.
[24] Velu V,Nandakumar S,Shanmugam S,et al.Comparison of three different recombinant hepatitis B vaccines:GeneVac-B, Engerix B and Shanvac B in high risk infants born to HBsAg positive mothers in India. World J Gastroenterol,2007,13(22):3084-3089.
[25] Yang SG,Tian G,Cui YX,et al.Factors influencing immunologic response to hepatitis B vaccine in adults. Sci Rep,2016,6:27251.

乙肝疫苗联合乙型肝炎免疫球蛋白接种阻断血清HBsAg阳性母亲HBV母婴传播效果分析^*

Efficacy of combination inoculation of hepatitis B vaccine and hepatitis B immunoglobulin on blocking mother-to-child transmission of hepatitis B virus infection in newborn with serum HBsAg/HBeAg-positive mothers

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	马丽英, 沈利娟. 妊娠后期应用替诺福韦治疗血清HBV高载量孕妇阻断HBV母婴传播的疗效及安全性分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 836-839.
[2]	陈嵘, 黄美玲, 凌雪梅, 林小红, 曾俊, 黎云, 夏建红. 替比夫定联合HBIG和乙肝疫苗阻断HBV母婴传播临床效果分析*[J]. 实用肝脏病杂志, 2019, 22(5): 752-753.
[3]	丁洋, 窦晓光. 如何实现乙型肝炎病毒母婴“零”传播?[J]. 实用肝脏病杂志, 2019, 22(1): 4-5.
[4]	朱娅鸽, 雷春梅, 郭丹丹, 陈天艳. 慢性乙型肝炎病毒感染孕妇及其婴幼儿随访管理研究^*[J]. 实用肝脏病杂志, 2019, 22(1): 45-48.
[5]	谭静, 叶晓林, 王慧. 妊娠中晚期应用替比夫定阻断HBsAg阳性孕妇HBV母婴传播效果及对婴儿接种乙肝疫苗应答的影响^*[J]. 实用肝脏病杂志, 2019, 22(1): 49-52.
[6]	陈奋, 林道炯. 母亲血清抗-HBs阳性对其新生儿接种乙肝疫苗接种效果的影响研究[J]. 实用肝脏病杂志, 2018, 21(4): 557-560.
[7]	张婧, 陈睿, 徐娜, 成西侠, 张玲玲, 陈慧芸. 西安市人群乙肝疫苗接种效果和血清抗-HBs阳性率抽样调查分析*[J]. 实用肝脏病杂志, 2018, 21(2): 279-280.
[8]	韩玉龙, 苗健, 尹家俊. 不同肝血流阻断方案对手术切除原发性大肝癌患者治疗效果比较[J]. 实用肝脏病杂志, 2018, 21(1): 104-107.
[9]	包依夏姆·阿巴拜克力, 努力比亚·阿不杜克尤木, 张跃新. 乙肝疫苗联合HBIG接种阻断HBsAg/HBeAg双阳性孕妇HBV母婴传播的效果研究[J]. 实用肝脏病杂志, 2017, 20(4): 481-482.
[10]	赵媛，曹耀章，房荣，张建军. 替比夫定对HBV高载量孕妇母婴传播阻断的疗效及安全性：一项随机对照研究*[J]. 实用肝脏病杂志, 2017, 20(2): 157-160.
[11]	包依夏姆·阿巴拜克力, 努力比亚·阿不杜克尤木, 张跃新. 乙肝疫苗联合HBIG接种阻断HBsAg/HBeAg双阳性孕妇HBV母婴传播的效果研究[J]. 实用肝脏病杂志, 2017, 20(2): 248-249.
[12]	聂云天, 郭丽娜, 刘淑斌, 田艳君, 张立杰, 张国侠. 齐齐哈尔市某高校人群血清乙型肝炎病毒流行病学调查^*[J]. 实用肝脏病杂志, 2016, 19(5): 601-602.
[13]	邱波, 朱玲, 陈艳, 吴晓丽, 刘秀丽, 王堂明, 严世春, 刘星妤. 妊娠期不同阶段给予替比夫定阻断乙型肝炎病毒宫内母婴传播的研究[J]. 实用肝脏病杂志, 2016, 19(4): 428-431.
[14]	康富标, 孙殿兴, 李东, 王君平, 杨新英, 王燕, 李海军. 干扰素-α2b治疗非母婴传播HBeAg阳性慢性乙型肝炎患者疗效分析[J]. 实用肝脏病杂志, 2016, 19(4): 471-472.
[15]	张先华. 替比夫定阻断血清HBV高载量孕妇母婴传播的疗效和安全性观察^*[J]. 实用肝脏病杂志, 2015, 18(4): 411-412.